Top 7 UI/UX Design Agencies for Healthcare in 2026

Healthcare is where IDEO's method shows most clearly, because the obvious solution in a clinical context is usually the wrong one. Engagements begin upstream of the brief, mapping the problem before anyone proposes an answer, and the output of an early phase is frequently a redefinition of what the service should be rather than a design for what was asked. Their published work with Kooth on a mental health platform is the current reference point.

Research and structural thinking are the core strengths. Accessibility is harder to judge from the outside, which is worth noting on a healthcare page specifically, since much of the output is service and strategy work that cannot be tested as a deployed interface.

Ranked second because the two things healthcare depends on most, research and accessibility, are where Blink is strongest. Research is the core strength, and accessibility is close behind. Founded as a usability research consultancy in 2000 and expanded into design afterward, which is the reverse of how most firms here arrived.

Blue Cross Blue Shield is the payer-side credential and federal government work is the public health one. Both force the constraints healthcare briefs actually carry: statutory accessibility obligations, procurement scrutiny, and user populations of extraordinary diversity. The lowest budget tier on this page by a distance. The profile carries the most linked sources here, though review volume is modest for a firm of this age.

Healthcare sits in the stated practice rather than appearing as one client logo, and seventeen studios means a health system programme can be staffed across several markets with local clinical and regulatory differences handled locally. That combination is rare, and it is the specific reason to consider them over a single-market specialist. The published client roster is weighted toward automotive, financial services, and retail, so ask for health references directly.

The method is documented: the JFK Terminal 4 case study shows competitive benchmarking, user interviews, and stakeholder workshops producing more than 500 ideas synthesised into eighteen concepts with implementation roadmaps. They also publish a responsible design framework applied at every project stage, which matters in a category where the ethical questions are not optional.

Public sector service design is the transferable credential here. A health service is a service before it is an interface, and Doberman map service journeys and identify systemic failure points before touching screens. The first phase is always scoped as paid research, and they will decline a brief that arrives with the solution already chosen, which is the right posture for a clinical problem.

Research and structural depth are the strengths, and both are earned by method rather than asserted. The gap is a named healthcare client: the Swedish government work is the closest evidence and it is public sector rather than clinical. This profile also carries a single linked source, the thinnest verification on the page.

It ranks fifth here, which needs explaining. Clay Global's shipped products and independent review record are among the strongest we have assessed, and healthcare is named in their stated practice. What they do not have is a published healthcare client, so the sector credential rests on the practice description rather than on shipped clinical work.

Where they are the right call is a digital health product that behaves like a software product: a patient app, a provider dashboard, a benefits platform. Strategy, UX, visual design, and front-end run as parallel disciplines, which keeps the patient-facing and clinician-facing halves consistent rather than scoped apart. Where the brief is a clinical service redesign or a regulated device interface, the four agencies above have the evidence and Clay Global does not.

Providence Health is a named healthcare client and the practice is built around considering the ethical and systemic implications of design decisions alongside the functional ones. In healthcare that discipline is not a philosophical extra: interface decisions have direct patient welfare consequences, and a system that nudges a clinician toward the wrong default causes harm rather than friction.

As AI-assisted interfaces enter clinical settings, that orientation moves from the edge of the field toward its centre, and Artefact have been working on it for over two decades. Research is the strength. Independent signals are held down by a limited verified review record and little recent editorial coverage.

Accessibility built in at the foundation layer is the whole argument for their place here. Healthcare interfaces are used by people with impaired vision, limited dexterity, cognitive load from illness or medication, and by carers operating on someone else's behalf. Clearleft build for that at the token and foundation layer rather than remediating afterward, which is the cheapest place to solve it and the place almost nobody does.

Be clear about what is missing. There is no healthcare client on the published roster, so this is capability rather than sector experience, and Citizens Advice is the closest analogue as a public service used under stress. The studio carries almost no marketplace review presence, so ask for references directly. Two decades of published writing on progressive enhancement is the compensating evidence.